Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.
BACKGROUND: Hydroxychloroquine is used for the treatment of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Long term studies have shown a high rate of termination of hydroxychloroquine treatment in patients with RA. Although it has been shown that discontinuation of treatment with...
שמור ב:
| הוצא לאור ב: | Ann Rheum Dis |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
1992
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004927/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1485814/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.51.12.1318 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|